Merck KGaA, Pfizer get priority review for bladder cancer drug German drugmaker Merck KGaA and U.S. partner Pfizer have been granted priority review status in the United States as they seek to widen the use of immunotherapy drug avelumab to include bladder cancer.
Merck drug prevents serious infection after marrow transplant: study An experimental Merck & Co drug succeeded in preventing clinically serious cytomegalovirus (CMV) following bone marrow transplant and was associated with a lower death rate compared with placebo in a late state study, the company said.
Family honors son with $1.25M donation to help blood cancer patients enroll in clinical trials A Minnesota family’s recent $1.25 million donation to the Be The Match Foundation will go toward building a better network for patients and families desperately searching for potentially life-saving clinical trials.
6-year-old's snowboarding injury leads to inoperable brain tumor diagnosis For the family of 6-year-old Devin Suau, every day is a race against the clock.
Many US cancer patients struggle to afford life-saving medications As cancer drug costs rise, U.S. cancer patients are more likely than other medical patients to struggle with paying for prescription medications, according to a recent study.
Many pacemaker recipients can safely get non-chest MRIs It might be possible for people with an older pacemaker to safely get an MRI after all.
Mom shares heartbreaking photo of 10-year-old son fighting cancer A Texas mother’s Facebook post about her young son battling cancer has gone viral.
6-year-old battling brain cancer celebrates birthday with superhero-themed party It was a birthday mission for a pint-sized Caped Crusader.
Exercise linked to better breast cancer outcomes Several lifestyle changes can improve outcomes after a breast cancer diagnosis, but exercise is far and away the best habit to establish, researchers say.
